Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population

OBJECTIVES: In a context of COVID-19 vaccine shortages, this study sought to evaluate the safety and efficacy of receiving one dose of Gam-COVID-Vac rAd26 followed by a second COVID-19 vaccine dose of either Gam-COVID-Vac rAd5, ChAdOx1 nCoV-19 or BBIBP-CorV in a cohort of older adults. STUDY DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundro, M.A., Losso, M.H., Macchia, A., Pastor, I., Alonso Serena, M., Gestoso, C., Moreno Macías, L., Crupi, F., Acosta, M.C., Ivalo, S., Ghioldi, M., Bouzas, M.B., Mammana, L., Zapiola, I., Mazzitelli, I., Varese, A., Geffner, J., Biscayart, C., Angeleri, P., Lopez, E., Gentile, A., Ferrante, D., de Quiros, F. Gonzalez B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444309/
https://www.ncbi.nlm.nih.gov/pubmed/36090797
http://dx.doi.org/10.1016/j.puhip.2022.100313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444309/
https://www.ncbi.nlm.nih.gov/pubmed/36090797
http://dx.doi.org/10.1016/j.puhip.2022.100313

Ejemplares similares